跳至主要内容
临床试验/JPRN-UMIN000024859
JPRN-UMIN000024859已完成未知

The effectiveness of motor and psychiatric symptoms for Parkinson's disease patients by switching from Dopamine agonist to Zonisamide or combining Dopamine agonist and Zonisamide. - The effectiveness of motor and psychiatric symptoms for Parkinson's disease patients by switching from Dopamine agonist to Zonisamide or combining Dopamine agonist and Zonisamide.

Medical Corporation Abe Neurology Clinic0 个研究点目标入组 50 人开始时间: 2016年11月16日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • •1)Patients who have taken zonisamide within 6 months from the start of study drug administration
  • •2)Patients with cognitive impairment of MMSE score 23 or less
  • •3)Patients who have undergone surgical therapy for parkinsonism, including stereotactic neurosurgery
  • •4)Pregnant or possibly pregnant women, women of childbearing potential who do not agree to use appropriate contraceptive measures, or breast-feeding women
  • •5)Patients who, in the opinion of the investigator or other study personnel, are unsuitable for the study

研究者

发起方
Medical Corporation Abe Neurology Clinic

相似试验